Denosumab for treatment of hypercalcemia of malignancy.
Journal of Clinical Endocrinology and Metabolism.
Times cited: 35
Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment.
Journal of the National Cancer Institute.
Times cited: 24